While the exact mechanisms are still being explored, researchers believe GLP-1s may impact the brains reward pathways, which could have implications for alcohol use disorder
5 Lower doses: Eight in ten real-world patients were on maintenance doses below 1.7 mg of semaglutide or 10 mg of tirzepatide
Broad Application in Cardiovascular Concerns: Major Potential In 2025, crucial research activities will be developing new applications of GLP-1 receptor agonists in heart conditions, including protective effects on the heart and blood vessels, probably decreasing the risk of heart attack, stroke, and other cardiovascular events
Young people deserve a health care system that values our lives, and illicit weight-loss drugs are not part of that
It is FDAapproved at specific doses and brand names for type 2 diabetes and chronic weight management in defined populations when combined with lifestyle interventions
More safety data is still being studied